SEC Form 4 · accession 0001596771-19-000016
NEUROONE MEDICAL TECHNOLOGIES Corp · NMTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Heuler
Officer — Vice President of Sales
Period of report
Jan 1, 2019
Accepted (ET)
Mar 1, 2019 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001500198
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1,F2 | $2.20 | Jan 1, 2019 | A | 100,365 | A | — | Jan 1, 2029 | Common Stock | 100,365 | 100,365 | D |
Explanation of responses
- F1On February 27, 2019, the Board of Directors of the Issuer determined that the fair market value of the Company's common stock as of January 1, 2019 was $2.20 per share.
- F225% of the options were immediately exercisable, and the remaining options will vest in 36 equal monthly installments beginning on January 1, 2020.